Literature DB >> 11589377

Effect of glucagon, glicentin, glucagon-like peptide-1 and -2 on interdigestive gastroduodenal motility in dogs with a vagally denervated gastric pouch.

C Shibata1, H Naito, X L Jin, T Ueno, Y Funayama, K Fukushima, A Hashimoto, S Matsuno, I Sasaki.   

Abstract

BACKGROUND: We previously reported that inhibition of gastric motility and hypertrophy of the small intestinal mucosa were observed after ileo-jejunal transposition which induced hypersecretion of enteroglucagon. Our aim was to study the effect of four enteroglucagon-related peptides (glucagon, glucagon-like peptide (GLP)-1, -2 and glicentin) on gastroduodenal motility and their mechanisms of action.
METHODS: The effect of these four peptides on motilin-induced interdigestive contractions was studied in dogs with vagally denervated gastric pouches equipped with four strain gauge force transducers on the pouch, gastric body, antrum and duodenum. Whether or not nitric oxide synthase inhibitor or phentolamine and propranolol reverses the inhibitory effect of those peptides was also studied.
RESULTS: Glucagon inhibited contractions in the pouch and stomach but had no effect on duodenal contractility. GLP-1 inhibited contractions at all sites. GLP-2 inhibited contractions in the pouch but did not affect motility in the neurally intact gastroduodenum. Glicentin had no effect on contractions at any site. Pretreatment with either a nitric oxide synthase inhibitor or phentolamine and propranolol reversed the inhibitory effect of glucagon, GLP-1 and GLP-2 on contractions in the pouch, but did not alter the inhibitory effect of glucagon and GLP-1 on motility in the neurally intact stomach and duodenum.
CONCLUSIONS: These results suggest that the effects of four peptides on gastroduodenal motility differ, and changes occur in the enteric neural modulation of motor activity after chronic surgical extrinsic denervation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11589377     DOI: 10.1080/003655201750422648

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  10 in total

1.  Two-channel gastric pacing with a novel implantable gastric pacemaker accelerates glucagon-induced delayed gastric emptying in dogs.

Authors:  Junying Xu; Robert A Ross; Richard W McCallum; Jiande D Z Chen
Journal:  Am J Surg       Date:  2008-01       Impact factor: 2.565

Review 2.  Gut hormones, and short bowel syndrome: the enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation.

Authors:  G-R Martin; P-L Beck; D-L Sigalet
Journal:  World J Gastroenterol       Date:  2006-07-14       Impact factor: 5.742

3.  Effect of ileo-jejunal transposition on ileal longitudinal smooth muscle contractility in vitro in rats.

Authors:  Chikashi Shibata; Yuji Funayama; Kouhei Fukushima; Tatsuya Ueno; Munenori Nagao; Hiroo Naito; Michiaki Unno; Ken-ichi Shiiba; Seiki Matsuno; Iwao Sasaki
Journal:  J Gastrointest Surg       Date:  2004-12       Impact factor: 3.452

4.  The effect of a total colectomy on the motor inhibition of the upper gut induced by intraileal stimuli in conscious dogs.

Authors:  Munenori Nagao; Chikashi Shibata; Yuji Funayama; Kouhei Fukushima; Koh Miura; Hitoshi Ogawa; Tatsuya Ueno; Katsuyoshi Kudoh; Michiaki Unno; Iwao Sasaki
Journal:  Surg Today       Date:  2009-09-24       Impact factor: 2.549

5.  The effect of growth hormone releasing peptide-2 on upper gastrointestinal contractile activity and food intake in conscious dogs.

Authors:  Katsuyoshi Kudoh; Chikashi Shibata; Yuji Funayama; Kouhei Fukushima; Tatsuya Ueno; Keiichi Hayashi; Akio Inui; Cyril Y Bowers; Iwao Sasaki
Journal:  J Gastroenterol       Date:  2009-03-07       Impact factor: 7.527

6.  Role of nitric oxide in gastric motor and sensory functions in healthy subjects.

Authors:  S D Kuiken; M Vergeer; S H Heisterkamp; G N J Tytgat; G E E Boeckxstaens
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

Review 7.  Insights on glicentin, a promising peptide of the proglucagon family.

Authors:  Juliette Raffort; Fabien Lareyre; Damien Massalou; Patrick Fénichel; Patricia Panaïa-Ferrari; Giulia Chinetti
Journal:  Biochem Med (Zagreb)       Date:  2017-06-15       Impact factor: 2.313

8.  Glucagon's Metabolic Action in Health and Disease.

Authors:  Anja Zeigerer; Revathi Sekar; Maximilian Kleinert; Shelly Nason; Kirk M Habegger; Timo D Müller
Journal:  Compr Physiol       Date:  2021-04-01       Impact factor: 9.090

Review 9.  Proglucagon-Derived Peptides as Therapeutics.

Authors:  Ryan A Lafferty; Finbarr P M O'Harte; Nigel Irwin; Victor A Gault; Peter R Flatt
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-18       Impact factor: 5.555

Review 10.  Neurohormonal Changes in the Gut-Brain Axis and Underlying Neuroendocrine Mechanisms following Bariatric Surgery.

Authors:  Eirini Martinou; Irena Stefanova; Evangelia Iosif; Angeliki M Angelidi
Journal:  Int J Mol Sci       Date:  2022-03-19       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.